Product NDC: | 55154-1125 |
Proprietary Name: | FORTAZ |
Non Proprietary Name: | ceftazidime |
Active Ingredient(s): | 20 mg/mL & nbsp; ceftazidime |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55154-1125 |
Labeler Name: | Cardinal Health |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050578 |
Marketing Category: | NDA |
Start Marketing Date: | 19920826 |
Package NDC: | 55154-1125-5 |
Package Description: | 5 VIAL in 1 BAG (55154-1125-5) > 50 mL in 1 VIAL |
NDC Code | 55154-1125-5 |
Proprietary Name | FORTAZ |
Package Description | 5 VIAL in 1 BAG (55154-1125-5) > 50 mL in 1 VIAL |
Product NDC | 55154-1125 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ceftazidime |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19920826 |
Marketing Category Name | NDA |
Labeler Name | Cardinal Health |
Substance Name | CEFTAZIDIME SODIUM |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes |